Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

• Ngā kaituhi matua: Hamdy SM (Author), Abdel-Naseer M (Author), Shehata HS (Author), Hassan A (Author), Elmazny A (Author), Shalaby NM (Author), Abokrysha NT (Author), Kishk NA (Author), Nada MAF (Author), Ahmed SM (Author), Hegazy MI (Author), Mekkawy D (Author), Mourad HS (Author), Abdelalim A (Author), Berger T (Author)
• Hōputu: Pukapuka
• I whakaputaina: Dove Medical Press, 2020-07-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Sherif M Hamdy,1 Maged Abdel-Naseer,1 Hatem S Shehata,1 Amr Hassan,1 Alaa Elmazny,1 Nevin M Shalaby,1 Noha T Abokrysha,1 Nirmeen A Kishk,1 Mona AF Nada,1 Sandra M Ahmed,1 Mohamed I Hegazy,1 Doaa Mekkawy,1 Husam S Mourad,1 Ahmed Abdelalim,1 Thomas Berger2 1Neurology Department, Faculty of Medicine, C...